Xeris Biopharma Holdings Inc.: Why Investors Shouldn't Get Rid Of XERS Stock In 2022

Retrieved on: 2022-12-26 18:01:29

Tags for this article:

Click the tags to see associated articles and topics

Xeris Biopharma Holdings Inc.: Why Investors Shouldn't Get Rid Of XERS Stock In 2022. View article details on hiswai:

Excerpt

In the last trading session, 0.38 million shares of the Xeris Biopharma Holdings Inc. (NASDAQ:XERS) were traded, and its beta was 1.39.

Article found on: marketingsentinel.com